Lionco Pharmaceutical Group Co.,Ltd. (SHA:603669)
China
· Delayed Price · Currency is CNY 5.23
+0.22 (4.39%)
Jun 6, 2025, 2:45 PM CST
Lionco Pharmaceutical Group Company Description
Lionco Pharmaceutical Group Co., Ltd., together with its subsidiaries, research and development, production, sales and medical services in China.
The company offers nutrition, antimicrobial, antiviral, digestion, cardiovascular, detoxification, anti-tumor, and other products.
Its project under research covers major disease areas such as anti-tumor, liver disease, and cerebrovascular drugs.
The company was founded in 2003 and is based in Shannan, China.
Lionco Pharmaceutical Group Co.,Ltd.
| Country | China |
| Founded | 2003 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 436 |
| CEO | Ling Ping Tao |
Contact Details
Address: Commercial and Residential Building 2 Shannan, 856000 China | |
| Phone | 86 89 8783 0666 |
| Website | lingkang.com.cn |
Stock Details
| Ticker Symbol | 603669 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE1000022R8 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Ling Ping Tao | GM and Chairman of the Board |
| Jun Ke Zhang | Accounting Supervisor, Financial Director and Secretary of the Board of Directors |
| Xiao Gang Tao | Deputy GM, Acting Secretary and Director |